We’re starting to understand the interaction of sickle blood with blood vessels, … That’s being now applied to treatments that actually improve outcome.

Drug companies are interested in diseases that millions of people get, … That’s where the profits are.

Bone marrow transplant is moving forward slowly,

It’s hard to get funding or people interested in trials, … But because this is a lifelong, chronic problem, it has a greater impact.